Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

MYELOFIBROSIS side effect

What is MYELOFIBROSIS ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with MYELOFIBROSIS

ANAGRELIDE  EFFEXOR  EXJADE  IMATINIB  INTRON  PROCRIT  REVLIMID  RITUXAN  THALOMID  


MYELOFIBROSIS : Rituxan Side Effects Report #5598371-6
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Jan 11, 2008. Male patient was diagnosed with haemolytic anaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, pancytopenia, . RITUXAN dosage: unknown. Patient recovered.

MYELOFIBROSIS : Effexor Side Effects Report #5565129-3
EFFEXOR problem was reported by a Health Professional from FRANCE on Dec 17, 2007. Female patient was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, pancytopenia, . EFFEXOR dosage: unknown. During the same period patient was treated with LEXOMIL, ABUFENE, BETASERC, SERMION, DOLIPRANE, TAHOR, AMYLASE. Patient was hospitalized. Patient recovered.

MYELOFIBROSIS : Exjade Side Effects Report #5448249-3
Consumer or non-health professional from UNITED STATES reported EXJADE problem on Sept 07, 2007. Female patient was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, platelet count decreased, . EXJADE dosage: unknown. Patient died on 05/01/2007.

MYELOFIBROSIS : Revlimid Side Effects Report #5671680-8
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, 80 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN D, ORAL. Patient died on 02/04/2008.

MYELOFIBROSIS : Anagrelide Side Effects Report #5688192-8
Physician from SWEDEN reported ANAGRELIDE HYDROCHLORIDE problem on Mar 12, 2008. Male patient was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with ANAGRELIDE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, platelet count decreased, . ANAGRELIDE HYDROCHLORIDE dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.

MYELOFIBROSIS : Revlimid Side Effects Report #5571116-1
REVLIMID problem was reported by a Physician from UNITED STATES on Dec 13, 2007. Male patient, 78 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL; 10 MG, IN 1 IN D, ORAL. Patient died on 11/09/2007.

MYELOFIBROSIS : Revlimid Side Effects Report #5483612-6
Physician from UNITED STATES reported REVLIMID problem on Oct 02, 2007. Female patient, 63 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, QD, ORAL. Patient died on 03/26/2007.

MYELOFIBROSIS : Imatinib Side Effects Report #5489047-4
IMATINIB problem was reported by a Health Professional from GERMANY on Oct 09, 2007. Male patient, 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, myelofibrosis, platelet count decreased, splenomegaly, white blood cell count increased, . IMATINIB dosage: 400 MG/D. Patient recovered.

MYELOFIBROSIS : Revlimid Side Effects Report #5453517-5
Health Professional from UNITED STATES reported REVLIMID problem on Sept 11, 2007. Male patient, 68 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2007.

MYELOFIBROSIS : Revlimid Side Effects Report #5471207-X
REVLIMID problem was reported by a Physician from UNITED STATES on Sept 20, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome, myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 08/01/2007.

MYELOFIBROSIS : Intron Side Effects Report #5379335-4
Consumer or non-health professional from UNITED STATES reported INTRON A problem on June 26, 2007. Female patient was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.

MYELOFIBROSIS : Intron Side Effects Report #5396876-4
INTRON A problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient, 54 years of age, weighting 115.0 lb, was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.

MYELOFIBROSIS : Intron Side Effects Report #5379335-4
Consumer or non-health professional from UNITED STATES reported INTRON A problem on June 26, 2007. Female patient was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.

MYELOFIBROSIS : Intron Side Effects Report #5396876-4
INTRON A problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient, 54 years of age, weighting 115.0 lb, was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.

MYELOFIBROSIS : Revlimid Side Effects Report #5635795-2
Health Professional from SPAIN reported REVLIMID problem on Feb 15, 2008. Male patient was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG,DAILY,ORAL. Patient died.

MYELOFIBROSIS : Procrit Side Effects Report #5592920-X
PROCRIT problem was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, bone marrow failure, myelofibrosis, thrombocytopenia, . PROCRIT dosage: unknown. During the same period patient was treated with ARANESP, TOPROL, FISH OIL, SINGULAIR, VITAMIN B6, DANAZOL, ACYCLOVIR, LIPITOR. Patient recovered.

MYELOFIBROSIS : Thalomid Side Effects Report #5481944-9
Physician from UNITED STATES reported THALOMID problem on Oct 02, 2007. Female patient, 54 years of age, was diagnosed with myelofibrosis and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: disease progression, malaise, myelofibrosis, polycythaemia, respiratory arrest, . THALOMID dosage: 50 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 09/07/2007.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about MYELOFIBROSIS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about MYELOFIBROSIS